Influence of Overweight on Surgical Complications for Gastric Cancer: Results From a Randomized Control Trial Comparing D2 and Extended Para-aortic D3 Lymphadenectomy (JCOG9501)
Toshimasa Tsujinaka(Osaka National Hospital), Yoshitaka Yamamura(Aichi Cancer Center), Seiichiro Yamamoto(National Cancer Centre Japan), Yukinori Kurokawa(The University of Osaka), Toshio Shimizu(Kansai Medical University), Mitsuru Sasako(Yodogawa Christian Hospital), Hiroshi Furukawa(University of Tsukuba), Akira Kurita(Shikoku Cancer Center), Masahiro Hiratsuka(Osaka International Cancer Institute), Takeshi Sano(The University of Tokyo), Satoru Inoue(Tokyo Metropolitan Bokutoh Hospital), Kuniyoshi Arai(Tokyo Metropolitan Komagome Hospital), Atsushi Nashimoto(Niigata Cancer Center Hospital), Taira Kinoshitá(National Cancer Center Hospital East), Hitoshi Katai
Cited by 141
Related Papers
E-CELL: software environment for whole-cell simulation.
|Bioinformatics|1999|765
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501